Mastelli’s approach to the management of acute and chronic skin wounds is based on the use of original and natural raw materials extracted by means of a peculiar method that produces a synergic action for accelerating the healing of wounds, ulcers, bedsores, and burns.
DRUGS /MEDICINAL PRODUCTS
Placentex
containing Polydeoxiribonucleotides PDRN, a pharmaceutical active ingredient
- Placentex “5,625 mg/3 ml injectable solution” 5 x 3 ml ampoules;
- Placentex “2,25 mg/3 ml injectable solution” 5 x 3 ml ampoules;
- Placentex “0,75 mg/3 ml skin solution” 10 x 3 ml ampoules;
- Placentex “0,08% cream” 25 g tube.
For an up-to-date Summary of Product Characteristics (SPC) and Information Leaflet (IL), refer to the site of AIFA (Agenzia Italiana del Farmaco, the Italian Medicines Agency).
MEDICAL DEVICES
Nucliaskin Line Class III MD CE0373
Containing Polynucleotides HPT™ and Hyaluronic Acid
Nucliaskin S
Gel containing Polynucleotides HPT™ e Hyaluronic Acid. Advanced medication for the treatment of ulcers and skin lesions – 2 ml pre-filled syringe
Nucliaskin Oral Care
Protective gel for the oral mucosa containing Polynucleotides HPT™ and Hyaluronic Acid. The gel promotes the reparative processes in the event of aphthae or lesions – 15 g tube
THERAPEUTIC AREAS
